Reviewed clinical policy
The below policies have been reviewed and agreed by Lancashire and South Cumbria Integrated Care Board, following a public engagement period which consisted of online surveys and focus groups.
Implementation of new clinical policy
We wish to bring to the attention of patients and members of the public that a revised clinical commissioning policy on the following treatment has been approved and will be used across NHS Lancashire and South Cumbria Integrated Care Board (ICB). This is the:
- Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Policy
This clinical policy explains the access criteria that must be met for these monitoring devices to be provided to diabetes patients on the NHS in this area.
The policy has been updated in keeping with the latest NICE guidance on the provision of continuous and flash glucose monitors. This makes them more widely available to type 1 and some type 2 diabetes patients, to children and young people and to pregnant patients.
You can read the policy in full further down on this page.
Arrangements are being made with GPs and hospital doctors and consultants, who are required to follow this policy when considering your treatment, for the implementation of this policy. Whilst this takes place there may be a period during which patients who were referred for treatment before this policy was approved may continue to be managed as they were originally referred.
If you have any questions about whether you are eligible for this treatment, you should discuss this with your GP/clinician.